Report Detail

Pharma & Healthcare Global Subcutaneous Immunoglobulins Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

  • RnM4652480
  • |
  • 05 December, 2025
  • |
  • Global
  • |
  • 74 Pages
  • |
  • GIR
  • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Subcutaneous Immunoglobulins market size was valued at US$ 5650 million in 2024 and is forecast to a readjusted size of USD 12210 million by 2031 with a CAGR of 11.8% during review period.
Subcutaneous Immunoglobulin (SCIg) infusions are administered by slowly injecting purified immunoglobulin into fatty tissue underneath the skin. SCIg can be administered at home by patients or carers, using an infusion pump (spring loaded or battery powered) or by rapid push (a manual method that does not require a pump).
In United States, Subcutaneous Immunoglobulins key players include Shire (Baxalta), Grifols, etc. Global top two manufacturers hold a share over 90%.
South is the largest market, with a share about 35%, followed by West, and Northeast, both have a share about 45 percent.
In terms of product, 10% Purity is the largest segment, with a share over 75%. And in terms of application, the largest application is Primary Immunodeficiency, followed by Secondary Immunodeficiency, etc.
This report is a detailed and comprehensive analysis for global Subcutaneous Immunoglobulins market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Purity and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Subcutaneous Immunoglobulins market size and forecasts, in consumption value ($ Million), sales quantity (K Bottle), and average selling prices (USD/Bottle), 2020-2031
Global Subcutaneous Immunoglobulins market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Bottle), and average selling prices (USD/Bottle), 2020-2031
Global Subcutaneous Immunoglobulins market size and forecasts, by Purity and by Application, in consumption value ($ Million), sales quantity (K Bottle), and average selling prices (USD/Bottle), 2020-2031
Global Subcutaneous Immunoglobulins market shares of main players, shipments in revenue ($ Million), sales quantity (K Bottle), and ASP (USD/Bottle), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Subcutaneous Immunoglobulins
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Subcutaneous Immunoglobulins market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Shire (Baxalta), Grifols, CSL, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Subcutaneous Immunoglobulins market is split by Purity and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Purity, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Purity
0.1
0.2
Market segment by Application
Primary Immunodeficiency
Secondary Immunodeficiency
Others
Major players covered
Shire (Baxalta)
Grifols
CSL
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Subcutaneous Immunoglobulins product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Subcutaneous Immunoglobulins, with price, sales quantity, revenue, and global market share of Subcutaneous Immunoglobulins from 2020 to 2025.
Chapter 3, the Subcutaneous Immunoglobulins competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Subcutaneous Immunoglobulins breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Purity and by Application, with sales market share and growth rate by Purity, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Subcutaneous Immunoglobulins market forecast, by regions, by Purity, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Subcutaneous Immunoglobulins.
Chapter 14 and 15, to describe Subcutaneous Immunoglobulins sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Purity
    • 1.3.1 Overview: Global Subcutaneous Immunoglobulins Consumption Value by Purity: 2020 Versus 2024 Versus 2031
    • 1.3.2 0.1
    • 1.3.3 0.2
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Subcutaneous Immunoglobulins Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Primary Immunodeficiency
    • 1.4.3 Secondary Immunodeficiency
    • 1.4.4 Others
  • 1.5 Global Subcutaneous Immunoglobulins Market Size & Forecast
    • 1.5.1 Global Subcutaneous Immunoglobulins Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Subcutaneous Immunoglobulins Sales Quantity (2020-2031)
    • 1.5.3 Global Subcutaneous Immunoglobulins Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Shire (Baxalta)
    • 2.1.1 Shire (Baxalta) Details
    • 2.1.2 Shire (Baxalta) Major Business
    • 2.1.3 Shire (Baxalta) Subcutaneous Immunoglobulins Product and Services
    • 2.1.4 Shire (Baxalta) Subcutaneous Immunoglobulins Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Shire (Baxalta) Recent Developments/Updates
  • 2.2 Grifols
    • 2.2.1 Grifols Details
    • 2.2.2 Grifols Major Business
    • 2.2.3 Grifols Subcutaneous Immunoglobulins Product and Services
    • 2.2.4 Grifols Subcutaneous Immunoglobulins Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Grifols Recent Developments/Updates
  • 2.3 CSL
    • 2.3.1 CSL Details
    • 2.3.2 CSL Major Business
    • 2.3.3 CSL Subcutaneous Immunoglobulins Product and Services
    • 2.3.4 CSL Subcutaneous Immunoglobulins Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 CSL Recent Developments/Updates

3 Competitive Environment: Subcutaneous Immunoglobulins by Manufacturer

  • 3.1 Global Subcutaneous Immunoglobulins Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Subcutaneous Immunoglobulins Revenue by Manufacturer (2020-2025)
  • 3.3 Global Subcutaneous Immunoglobulins Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Subcutaneous Immunoglobulins by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Subcutaneous Immunoglobulins Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Subcutaneous Immunoglobulins Manufacturer Market Share in 2024
  • 3.5 Subcutaneous Immunoglobulins Market: Overall Company Footprint Analysis
    • 3.5.1 Subcutaneous Immunoglobulins Market: Region Footprint
    • 3.5.2 Subcutaneous Immunoglobulins Market: Company Product Type Footprint
    • 3.5.3 Subcutaneous Immunoglobulins Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Subcutaneous Immunoglobulins Market Size by Region
    • 4.1.1 Global Subcutaneous Immunoglobulins Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Subcutaneous Immunoglobulins Consumption Value by Region (2020-2031)
    • 4.1.3 Global Subcutaneous Immunoglobulins Average Price by Region (2020-2031)
  • 4.2 North America Subcutaneous Immunoglobulins Consumption Value (2020-2031)
  • 4.3 Europe Subcutaneous Immunoglobulins Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Subcutaneous Immunoglobulins Consumption Value (2020-2031)
  • 4.5 South America Subcutaneous Immunoglobulins Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Subcutaneous Immunoglobulins Consumption Value (2020-2031)

5 Market Segment by Purity

  • 5.1 Global Subcutaneous Immunoglobulins Sales Quantity by Purity (2020-2031)
  • 5.2 Global Subcutaneous Immunoglobulins Consumption Value by Purity (2020-2031)
  • 5.3 Global Subcutaneous Immunoglobulins Average Price by Purity (2020-2031)

6 Market Segment by Application

  • 6.1 Global Subcutaneous Immunoglobulins Sales Quantity by Application (2020-2031)
  • 6.2 Global Subcutaneous Immunoglobulins Consumption Value by Application (2020-2031)
  • 6.3 Global Subcutaneous Immunoglobulins Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Subcutaneous Immunoglobulins Sales Quantity by Purity (2020-2031)
  • 7.2 North America Subcutaneous Immunoglobulins Sales Quantity by Application (2020-2031)
  • 7.3 North America Subcutaneous Immunoglobulins Market Size by Country
    • 7.3.1 North America Subcutaneous Immunoglobulins Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Subcutaneous Immunoglobulins Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Subcutaneous Immunoglobulins Sales Quantity by Purity (2020-2031)
  • 8.2 Europe Subcutaneous Immunoglobulins Sales Quantity by Application (2020-2031)
  • 8.3 Europe Subcutaneous Immunoglobulins Market Size by Country
    • 8.3.1 Europe Subcutaneous Immunoglobulins Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Subcutaneous Immunoglobulins Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Subcutaneous Immunoglobulins Sales Quantity by Purity (2020-2031)
  • 9.2 Asia-Pacific Subcutaneous Immunoglobulins Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Subcutaneous Immunoglobulins Market Size by Region
    • 9.3.1 Asia-Pacific Subcutaneous Immunoglobulins Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Subcutaneous Immunoglobulins Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Subcutaneous Immunoglobulins Sales Quantity by Purity (2020-2031)
  • 10.2 South America Subcutaneous Immunoglobulins Sales Quantity by Application (2020-2031)
  • 10.3 South America Subcutaneous Immunoglobulins Market Size by Country
    • 10.3.1 South America Subcutaneous Immunoglobulins Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Subcutaneous Immunoglobulins Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Subcutaneous Immunoglobulins Sales Quantity by Purity (2020-2031)
  • 11.2 Middle East & Africa Subcutaneous Immunoglobulins Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Subcutaneous Immunoglobulins Market Size by Country
    • 11.3.1 Middle East & Africa Subcutaneous Immunoglobulins Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Subcutaneous Immunoglobulins Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Subcutaneous Immunoglobulins Market Drivers
  • 12.2 Subcutaneous Immunoglobulins Market Restraints
  • 12.3 Subcutaneous Immunoglobulins Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Subcutaneous Immunoglobulins and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Subcutaneous Immunoglobulins
  • 13.3 Subcutaneous Immunoglobulins Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Subcutaneous Immunoglobulins Typical Distributors
  • 14.3 Subcutaneous Immunoglobulins Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Subcutaneous Immunoglobulins. Industry analysis & Market Report on Subcutaneous Immunoglobulins is a syndicated market report, published as Global Subcutaneous Immunoglobulins Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Subcutaneous Immunoglobulins market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report